ALLR

Allarity Therapeutics (ALLR) P/E Ratio
P/E Ratio as of Oct 26, 2026: -1.16
Average-1.19
Median-1.16
Minimum-1.34
Maximum-1.06
-1.16
0.15 (11.45%)past month
The P/E ratio for Allarity Therapeutics (ALLR) is -1.16 as of Oct 26, 2026. This represents a decrease of -7.20% compared to its 12-month average P/E ratio of -1.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Allarity Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Allarity Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Allarity Therapeutics to industry peers.
Allarity Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Allarity Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Allarity Therapeutics to industry peers.
Allarity Therapeutics (ALLR) P/E Ratio Insights
See Allarity Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Allarity Therapeutics (ALLR)
Order type
Buy in
Order amount
Est. shares
0 shares
Allarity Therapeutics (ALLR) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $1.04 | -1.32 |
| Sep 1, 2026 | $1.42 | -1.81 |
| Aug 3, 2026 | $1.27 | -1.76 |
| Jul 1, 2026 | $1.33 | -1.84 |
| Jun 1, 2026 | $1.72 | -2.38 |
| May 1, 2026 | $1.30 | -1.64 |
| Apr 1, 2026 | $1.13 | -1.42 |
| Mar 2, 2026 | $0.995 | -0.62 |
| Feb 2, 2026 | $0.9641 | -0.60 |
| Jan 2, 2026 | $1.14 | -0.71 |
Allarity Therapeutics (ALLR) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -1.16 | +73.13% |
| 2025 | -0.67 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | -0.07 | -98.31% |
| 2021 | -4.13 | — |
FAQs About Allarity Therapeutics (ALLR) P/E ratio
The latest P/E ratio of Allarity Therapeutics (ALLR) is -1.16, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Allarity Therapeutics’s last 12-month average P/E ratio is -1.25, compared to its current P/E ratio of -1.16. This reflects a decrease of -7.20%.
Allarity Therapeutics’s current P/E ratio of -1.16 is lower than its last 12-month average P/E of -1.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Allarity Therapeutics’s average P/E ratio over the last 3 years is -0.43. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Allarity Therapeutics’s average P/E ratio over the last 5 years is -0.55. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Allarity Therapeutics (ALLR) P/E Ratio Insights
See Allarity Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Allarity Therapeutics (ALLR)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.